Article
DNA methylation changes in prostate cancer: current developments and future clinical implementation
1 Apr 2009
Abstract excerpt
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor genes in cancer. Currently, several genome-wide technologies are available and have been utilized to examine the extent of DNA methylation in discovery-based studies involving several physiological and disease states. Although early in the process, aberrant DNA methylation is gaining strength in the fields of cancer risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
